[TLX] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
31-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -205.92%
YoY- -208.87%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 31/01/17 CAGR
Revenue 195 49 49 49 0 0 0 -
PBT -10,524 -5,190 -3,928 -4,806 -1,571 -1,594 -1,594 167.93%
Tax 1,884 -471 -471 -471 -38 -38 -38 -
NP -8,640 -5,190 -3,457 -4,806 -1,571 -1,556 -1,556 144.77%
Tax Rate - - - - - - - -
Total Cost 8,835 5,239 3,506 4,854 1,571 1,556 1,556 147.64%
Ratio Analysis
31/12/18 30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 31/01/17 CAGR
NP Margin -4,430.77 -10,638.53 -7,087.06 -9,850.62 0.00 0.00 0.00 -
Per Share
31/12/18 30/06/18 31/03/18 31/12/17 30/06/17 31/03/17 31/01/17 CAGR
EPS -0.04 -0.03 -0.02 -0.02 -0.64 -0.01 -0.01 106.24%
EPS Diluted -0.04 -0.03 -0.02 -0.02 -0.64 -0.01 -0.01 106.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.